Market Update by Liontrust – Q3 2024

Liontrust GF High Yield Bond Fund is manufactured by Liontrust Fund Partners LLP and represented in Malta by MeDirect Bank (Malta) plc.

Market review

The global high yield market returned an impressive 4.98% (US dollar terms) in the third quarter of 2024, with lower quality bonds in particular driving the pace of the market as the prospect of a soft landing in the US was increasingly baked into credit valuations. The US high yield market produced a return of 5.27%; in Europe the market returned 3.97%.

The return of US CCC-rated bonds was stellar at 11.55%, the best quarterly return for this lowest quality cohort since Q4 2020, and outperforming BBs by more than seven percentage points in the period. With regards to the yield spread between CCCs and BBs in the US over the last three years, as CCC-rated bonds are of lower credit quality and represent a higher risk, they have a higher yield on average. However, the strong recent performance of CCCs has driven this yield premium, or spread, down to just over six percentage points, compared with a little under eight points at the start of the quarter.

Fund performance

As you might expect given the quality skew of our process and philosophy, the marked outperformance of lower quality bonds explains the relative underperformance versus index. In other words, it’s what we didn’t own in the quarter explaining the deviation.

There were a limited number of individual bonds driving the strong absolute return of the Fund in the quarter. Real estate has continued to be a strong theme. We did reduce fund exposure to real estate in the early part of the summer, which with the benefit of hindsight was too soon. That being said, we saw strong performance from Aroundtown and, to a lesser extent, Castellum. Overall, real estate continued to be a positive contributor to Fund performance.

Less positively, two relatively recent additions, Brightline and Mahle, were the main negative contributors. With Brightline, we believe the market is showing impatience with its slow ramp up, but the company is scheduled to take delivery of rolling stock in Q4 and it should be an impressive 2025 growth story. Mahle, as a Europe-based auto supplier, is likely to have some tough quarters ahead as more and more auto equipment manufacturers issue profit warnings. Neither bond cost the Fund more than 5bps and both offer good compensation for the uncertainty.

Trade activity

We took new positions in Wilsonart (CCC), a US based producer of worktops; Arcosa (BB), a company making various infrastructure related products; French optical retailer, Alain Afflelou; and Bubbles (B), an Italian value retailer with an impressive growth trajectory.

Outlook

The high yield market has, in our view, moved a long way towards pricing in a soft landing. That being said, having outperformed BBs by over 7% in the quarter, it is feasible – if we do see a soft landing – that it could do the same again in the coming months. That is based on spreads between BB and CCC getting back to the QEfuelled tights of 2021. We are prepared to accept this opportunity cost as, by definition, any obstacles to the soft landing narrative will likely be most keenly felt in the CCC space.

The global high yield market has a yield to maturity a little over 7% (US dollar terms) and spread of around 320 basis points. If you view the market as a cousin of the equity market and use if for its long-term return potential, this 7% remains an interesting opportunity, in our view. If you view high yield within the fixed income complex and use it to make occasional total return gains versus government bonds, spreads are arguably on the tight side.

The Fund continues to invest in bonds based on strong corporate fundamentals and has a bias towards high quality defensive credits, with minimal exposure to cyclical credits. We believe our defensive approach stands us in good shape to perform if and when default risk is the major driver of the market, rather than interest rates. The Fund is currently offering yield of around 9.1% for sterling investors (and around 7.5% for euro investors), which we view as an attractive entry point.

 


Liontrust Key risks & Disclaimers:

Past performance is not a guide to future performance. Do remember that the value of an investment and the income generated from them can fall as well as rise and is not guaranteed, therefore, you may not get back the amount originally invested and potentially risk total loss of capital.

The issue of units/shares in Liontrust Funds may be subject to an initial charge, which will have an impact on the realisable value of the investment, particularly in the short term. Investments should always be considered as long term.

Investment in the GF High Yield Bond Fund involves foreign currencies and may be subject to fluctuations in value due to movements in exchange rates. The value of fixed income securities will fall if the issuer is unable to repay its debt or has its credit rating reduced. Generally, the higher the perceived credit risk of the issuer, the higher the rate of interest. Bond markets may be subject to reduced liquidity. The Fund may invest in emerging markets/soft currencies and in financial derivative instruments, both of which may have the effect of increasing volatility. The Fund may invest in derivatives. The use of derivatives may create leverage or gearing. A relatively small movement in the value of a derivative’s underlying investment may have a larger impact, positive or negative, on the value of a fund than if the underlying investment was held instead.

Issued by Liontrust Fund Partners LLP (2 Savoy Court, London WC2R 0EZ), authorised and regulated in the UK by the Financial Conduct Authority (FRN 518165) to undertake regulated investment business.

This document should not be construed as advice for investment in any product or security mentioned, an offer to buy or sell units/shares of Funds mentioned, or a solicitation to purchase securities in any company or investment product. Examples of stocks are provided for general information only to demonstrate our investment philosophy. It contains information and analysis that is believed to be accurate at the time of publication, but is subject to change without notice. Whilst care has been taken in compiling the content of this document, no representation or warranty, express or implied, is made by Liontrust as to its accuracy or completeness, including for external sources (which may have been used) which have not been verified. It should not be copied, faxed, reproduced, divulged or distributed, in whole or in part, without the express written consent of Liontrust. Always research your own investments and (if you are not a professional or a financial adviser) consult suitability with a regulated financial adviser before investing.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from Liontrust Fund Partners LLP. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instrument discussed in the document is intended for retail clients however, it may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

BlackRock Commentary: U.S. earnings strength stands out

Wei Li – Global Chief Investment Strategist of BlackRock Investment Institute together with Carrie King –
Chief Investment Officer of U.S. and Developed Markets, Fundamental Equities, Carolina Martinez
Arevalo – Portfolio Strategist and Michel Dilmanian – Portfolio Strategist all forming part of the BlackRock Investment Institute share their insights on global economy, markets and geopolitics. Their views are theirs alone and are not intended to be construed as investment advice.

Key Points

Broadening earnings: We think U.S. corporate earnings strength will keep broadening beyond tech in the Q3 season. We also see bright spots in Japan and European sectors.

Market backdrop: U.S. stocks ticked up last week to new record highs, powered by the ongoing rotation into small caps. U.S. 10-year Treasury yields hover near recent peaks.

Week ahead: This week, we eye euro area flash PMIs after the European Central Bank (ECB) cut interest rates for a third time. We think it will step up the pace of rate cuts.

U.S. stocks are hitting new highs – after a summer slump – as Q3 corporate earnings season kicks off. We prefer broad U.S. equities as we expect corporate earnings strength to keep broadening beyond tech. Federal Reserve rate cuts and solid economic activity underpin our U.S. view. We’re overweight Japanese stocks as earnings prove resilient to a stronger yen. Weak growth keeps us underweight European stocks overall, but we have favored sectors like financials.

Favoring stocks over bonds has been rewarded this year as equities have climbed to new highs. Even as doubts over tech investment in artificial intelligence (AI) and recession fears stoked volatility, U.S. stocks have outperformed other regions this year on earnings growth and soaring tech valuations. See the chart. Jitters about lofty valuations and U.S. election uncertainty can drive market volatility. Yet on a six- to 12-month horizon, we stay overweight U.S. stocks as markets expect double-digit earnings growth over the next year and falling interest rates. We’re overweight Japanese stocks. Strong earnings growth that has boosted stock performance is slowing but remains resilient to a stronger yen. Europe’s story is slightly different: Earnings have been weak given poor economic growth. We’re underweight euro area stocks overall but see bright spots in sectors like financials and healthcare.

We prefer U.S. over European stocks. The reason: The near-term macro backdrop supports risk-taking in the U.S., even as markets have priced out some rate cuts. The Fed is cutting even as growth and the labor market hold up. We think earnings strength will keep expanding beyond tech, narrowing the gap between tech and other sectors. Earnings for a handful of top companies, mostly tech-related, are expected to grow 19% next year, down from about 30% in 2023 and 2024. Analysts see earnings for the rest of the S&P 500 growing 4% this year and 14% in 2025 after contracting last year, FactSet data show.

Our evolving AI views

We see ample room for the AI theme to run: Its buildout is only in the early stages. Yet investor doubts about tech spending on AI linger. We’ve expanded our AI preference beyond tech to sectors like utilities, energy, real estate and industrials. U.S. utility earnings have grown 8.2% over the past year, the fastest since 2020, based on LSEG data, partly due to AI’s big energy need. Utilities are neck-and-neck with tech as the best-performing sector this year. Our portfolio managers note that industrial companies tied to the AI buildout are seeing more demand than their peers.

Our global stock picks

Outside the U.S, we stay positive on Japanese stocks after trimming our overweight as a stronger yen drags on earnings. Solid wage growth, stronger corporate pricing power and shareholder-friendly reforms support earnings growth. Elsewhere in Asia, hopes for major fiscal stimulus have halted earnings downgrades for Chinese stocks. We’ve turned overweight Chinese stocks given this policy signal but that doesn’t change the long-term, structural challenges we are concerned about.

We stay underweight euro area stocks given weak growth and a limited recovery. Q3 earnings are expected to grow just 3.7% from a year earlier, with revenues still contracting. Yet we have favored outperforming sectors like financials. We also get granular in healthcare as some businesses will benefit more from AI and other mega forces, or structural shifts. We prefer European healthcare companies over their U.S. peers as they face less risk of losing revenue due to drug patents expiring.

Our bottom line

As Q3 earnings season gets underway, we stay overweight U.S. stocks and expect earnings to strengthen in sectors beyond tech. We’re also overweight Japan’s stocks. We’re underweight European equities but get selective in sectors.

Market backdrop

U.S. stocks ticked up last week to new record highs as Q3 earnings season kicked off. Small-cap stocks led the climb, cruising to their highest level since 2021. Tech stocks rallied to end the week after chipmaker TSMC’s sunny outlook hinted at robust demand for AI chips. U.S. 10-year Treasury yields ebbed to around 4.08%, just off recent highs but still up around 50 basis points in the past month. The ECB cut rates by 25 basis points for the third time this year and signaled a faster pace of cuts.

Global flash PMIs are on tap this week. In the euro area, recent weak PMIs point to contracting business activity. Slowing growth, weaker employment and inflation undershooting projections prompted the ECB to cut policy rates by 25 basis points again last week. Incoming data will be key for an ECB that has vowed to take a meeting-by-meeting approach on future policy decisions. Yet we don’t see the ECB returning to the old regime of very easy monetary policy.

Week Ahead

Oct. 23: Euro area consumer confidence

Oct. 24: Global flash PMIs

Oct. 25: U.S. durable goods; Tokyo CPI


BlackRock’s Key risks & Disclaimers:

This material is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of 21st October, 2024 and may change. The information and opinions are derived from proprietary and non-proprietary sources deemed by BlackRock to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by BlackRock, its officers, employees or agents. This material may contain ’forward looking’ information that is not purely historical in nature. Such information may include, among other things, projections and forecasts. There is no guarantee that any forecasts made will come to pass. Reliance upon information in this material is at the sole discretion of the reader.

The information provided here is neither tax nor legal advice. Investors should speak to their tax professional for specific information regarding their tax situation. Investment involves risk including possible loss of principal. International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation, and the possibility of substantial volatility due to adverse political, economic or other developments. These risks are often heightened for investments in emerging/developing markets or smaller capital markets.

Issued by BlackRock Investment Management (UK) Limited, authorized and regulated by the Financial Conduct Authority. Registered office: 12 Throgmorton Avenue, London, EC2N 2DL.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from  BlackRock Investment Management (UK) Limited. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document is intended for retail clients however, it may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

You are leaving medirect.com.mt

Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.

 

Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.